Clinical impact of delays in the management of lung cancer patients in the last decade: systematic review
-
María Guirado [1] ; Elena Fernández Martín [2] ; Alberto Fernández Villar [3] ; Arturo Navarro Martín [4] ; Alfredo Sánchez-Hernández [5]
-
[1] Hospital General Universitario de Elche
Hospital General Universitario de Elche
Elche, España
-
[2] Hospital Clínico San Carlos de Madrid
Hospital Clínico San Carlos de Madrid
Madrid, España
-
[3] Pneumology Department, Hospital Álvaro Cunqueiro de Vigo, Instituto de Investigación Sanitaria de Vigo
-
[4] Radiation Oncology Department, Hospital Durani Reynals, Hospitalet, L’Hospitalet de Llobregat, Barcelona
-
[5] Medical Oncology Department, Consorcio Hospitalario Provincial de Castellón
-
- Localización: Clinical & translational oncology, ISSN 1699-048X, Vol. 24, Nº. 8, 2022, págs. 1549-1568
- Idioma: inglés
- Texto completo no disponible (Saber más ...)
-
Resumen
Introduction Due to the importance of lung cancer early treatment because of its severity and extent worldwide a systematic literature review was conducted about the impact of delays in waiting times on the disease prognosis.
Materials and Methods We conducted a systematic search of observational studies (2010-2020) including adult patients diagnosed with lung cancer and reporting healthcare timelines and their clinical consequences.
Results We included 38 articles containing data on waiting times and prognosis; only 31 articles linked this forecast to a specific waiting time. We identified 41 healthcare time intervals and found medians of 6-121 days from diagnosis to treatment and 4-19.5 days from primary care to specialist visit: 37.5% of the intervals indicated better prognosis with longer waiting times.
Conclusions All articles emphasized that waiting times must be reduced to achieve good management and prognosis of lung cancer. Further prospective studies are needed on the relationship between waiting times and prognosis of lung cancer.
